Present at the event, Jeffrey Zamora, President of ASOVAPE Costa Rica and Project Leader of the Veritas project, a research conducted by CoEHAR which will try to identify if there are any harmful effects of long-term regular vaping on respiratory health or other endpoints for people who never smoked.
Dr. Emma, researcher at the Replica project, is going to present: "Replica Project: A Journey Through Multicentric Research Endeavors". The appointment is set for June 14 at 11,30 am.
Thanks to additional funding from the PNRR Heal Italia, CoEHAR researchers are initiating further collaboration with the Universities of Bari and Palermo for the Diasmoke project.
Resident doctors, PhD students, young researchers, and masters students coordinated the CoEHAR annual meeting dedicated to the World No Tobacco Day 2024, sharing experiences from their own social contexts, including…
Stroke, heart attacks, neuropathies, retinopathies, diabetic nephropathies: choosing to smoke exacerbates the clinical picture of patients with diabetes. But can quitting change a critical health situation? According to the latest…
The meeting will be held on Thursday, May 30, at 8:30 AM in the Aula Magna of the Biological Tower at the University of Catania. The topics discussed will range from oral to sexual health, from sociology to marketing, from diagnosis to clinical treatment, also covering innovative solutions and new tools provided through the use of artificial intelligence.
The global action to end smoking grantmaking will continue to focus on advancing health and science research for cutting-edge smoking cessation and reduced-risk solutions, with a particular focus on marginalized communities and low- and middle-income countries where smoking is most widespread.
The results were included in the review "Behavioural therapy for people with diabetes who smoke: a scoping review," published in the Journal of Primary Care and Community Health: it is now clear that persons living with diabetes are not the subject of targeted treatments and that there is ample room for progress. It seems that more structured and intensive therapies could benefit these persons in bidding farewell to cigarette smoking, while little is still known about the possible benefits of combining behavioral therapies and nicotine replacement pharmacological therapies.
Catania, April 29, 2024 - This morning, as part of the April graduation session of the Bachelor's Degree in Biotechnology at the University of Catania, four more theses on the…
But how much would harm reduction and the reduction of smoking-related diseases affect international health policy strategies? Would there be fewer hospital admissions without conventional cigarette smoke? The answer will be provided by questionnaires administered to over 3000 hospitalized patients whose smoking habits and potential use of non-combustion products will be analyzed to assess the causes of hospital admission and the subsequent outcomes of the diseases identified.
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.